Achieving life sciences sector growth requires falling VPAG payment rates. In this piece, @TorbettR explains the drivers behind the UK's historic underinvestment in medicine and the unprecedented opportunity to address the issue in 2025. www.abpi.org.uk/media/blogs/...

To see the blog I posted this week on why we’ll be proposing a ‘course correct’ on VPAG. It’s an important scheme and we need it to work. Current rates will damage competitiveness unless we find a solution